Amoxicillin And Clavulanate Potassium
Product Images NDC 68071-2475

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Amoxicillin And Clavulanate Potassium (NDC 68071-2475). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2475 2)

Amoxicillin and Clavulanate Potassium 875mg/125mg tablets label from NuCare Pharmaceuticals, Inc. The label indicates a #20 tablet package with each tablet containing 875mg Amoxicillin trihydrate and 125mg Clavulanic Acid as Clavulanate Potassium. Includes NDC 68071-2475 and notes the product is prescription only (Rx Only). Additional manufacturer and batch information is shown with storage instructions to keep at 68-77°F.*

FDA Label Image

Table (Clinical Table)

A table presenting bacteriologic efficacy rates for Augmentin measured at different time points post therapy. It compares the efficacy percentages and sample sizes for two dosing regimens: 875 mg every 12 hours and 500 mg every 8 hours, with data shown for 2 to 4 days, 5 to 9 days, and 2 to 4 weeks.*

FDA Label Image

Image (Decription Image 1)

Chemical structure diagram of Amoxicillin and Clavulanate Potassium trihydrate, showing molecular components including a beta-lactam ring and other characteristic functional groups.*

FDA Label Image

Image (Decription Image 2)

Chemical structure of Amoxicillin and Clavulanate Potassium, showing the molecular configuration of the active ingredients.*

FDA Label Image

Image (Dosageand Admini Table1)

A data table titled 'Dosing in Patients Aged 12 weeks (3 months) and Older' for Amoxicillin and Clavulanate Potassium. It lists infections including otitis media, sinusitis, lower respiratory tract infections, and more severe infections, alongside dosing regimens for oral suspension at intervals of every 12 hours and every 8 hours with specific dosage amounts in mg/kg/day and mL, noting different strengths of the suspension.*

FDA Label Image

Table (Dosageand Admini Table2)

A table displaying the amount of water needed for reconstitution of Amoxicillin and Clavulanate Potassium oral suspensions at different strengths and bottle sizes. It includes measurements of water volume and corresponding amounts of amoxicillin and clavulanic acid per 5 mL teaspoonful.*

FDA Label Image

Table (Pharmacokine Table)

Two tables presenting pharmacokinetic parameters of Amoxicillin and Clavulanate Potassium with AUGMENTIN formulations. Table 3 summarizes mean peak concentration (Cmax) and area under the curve (AUC0-24) values for Amoxicillin/Clavulanate potassium in various doses of AUGMENTIN tablets administered every 8 to 12 hours. Table 4 shows similar parameters for AUGMENTIN powder for oral suspension and chewable tablets at specified doses. The data include standard deviations and note dosage timings relative to light meals in normal adults.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.